Drug intelligence / Profile preview

Liuzhen Capsule

Development stage: Preclinical
Lead developer: Lei Yun Shang
Administration: Oral

Overview

Liuzhen Capsule (六珍胶囊) is a Traditional Chinese Medicine (TCM) product currently in the research and development pipeline of Lei Yun Shang, a well-established Chinese pharmaceutical company. Formulated as an oral capsule, it is part of a broader product line that includes Liuzhenbao Gel and Liuzhenbao Oral Liquid. As a TCM formulation, it likely consists of a proprietary blend of herbal ingredients designed to work through multi-target synergistic effects, although its specific molecular targets and primary clinical indications are not disclosed in standard Western pharmaceutical formats on the developer's website. The drug is currently listed as being under research and development by the Lei Yunshang Group Institute of Chinese Medicine.

Brand names: Liuzhen Capsule
Other names: 六珍胶囊Liuzhen Capsule-Lei Yun Shang

Beyond the preview

Go deeper on Liuzhen Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liuzhen Capsule.

Explore the full profile